Cargando…
Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases
Megestrol is an effective palliative treatment for endometrial carcinoma. Some persons with progestin-responsive cancer continue on hormonal therapy for months or even years. In persons who respond to megestrol, long term use can cause weight gain and other side effects via activity of the drug at t...
Autores principales: | Read, William L., Trivedi, Sumita, Williams, Felicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647516/ https://www.ncbi.nlm.nih.gov/pubmed/29062884 http://dx.doi.org/10.1016/j.gore.2017.09.015 |
Ejemplares similares
-
Megestrol treatment in patients with hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2001) -
Norethindrone Acetate in the Medical Management of Adenomyosis
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012) -
Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
por: Shan, Weiwei, et al.
Publicado: (2014) -
Postablation Endometrial Carcinoma
por: Wortman, Morris, et al.
Publicado: (2017) -
Effectiveness of Megestrol for the Treatment of Patients with Atypical Endometrial Hyperplasia or Endometrial Endometrioid Adenocarcinoma (Stage IA, Well Differentiated)
por: Akhavan, Setareh, et al.
Publicado: (2021)